Funding Innovation in Biotech: A Conversation with Congress and Industry Analysts

Published on:
August 1, 2016
By:
  • Kyle Brandon

By: Kyle Brandon

It can take 14 years and up to $2 billion to bring a medicine to market. How does the biotech industry fund extraordinary innovations? Venture capital investments and capital markets (i.e. IPOs and secondary offerings).

Biotechnology is an evolving industry that improves lives through the development of treatments and cures for some of today’s most pressing medical challenges, while also fueling innovation, economic growth and job creation across America. At a roundtable discussion on Capitol Hill, Members of Congress and industry analysts from RBC Capital Markets and Jefferies discuss the state of the biotech industry today and the role of America’s capital markets in funding new

innovations.

Read More:

Biotech Hill Roundtable: A Conversation with Congress and the Financial Services Industry  

Biotechnology Roundtable Press Release

Biotechnology Fact Sheet: Funding Innovation in Biotechnology

Project Invested: How biotech investment is revolutionizing health care treatments

Project Invested: What You Need to Know About the Biotech Revolution in Agriculture

SIFMA would like to extend a special thank you to our roundtable participants who provided their expertise and delivered insights into this important segment: Representative French Hill (R-AR); Representative Scott Peters (D-CA); Representative Leonard Lance (R-NJ); Michael Yee, Managing Director, RBC Capital Markets; and Brian Abrahams, M.D., Managing Director, Jefferies. 

Details

More Content

  • Press Releases
    Nov 12, 2026

    SIFMA Fixed Income Market Close Recommendations in the U.S., the U.K., and Japan for Thanksgiving Day

    SIFMA confirmed its previous recommendations for the U.S., the U.K., and Japan in observance of the 2026 U.S. Thanksgiving Day holiday.
  • The SIFMA Podcast
    Nov 06, 2026

    Market Snapshot: What’s Ahead for the Economy and Markets? Featuring Steve Liesman, Scott Anderson and Mark Zandi

    meta description for this? Hear Steve Liesman, Scott Anderson and Mark Zandi discuss the 2027 economic outlook, GDP growth forecasts, Fed policy and key market risks on SIFMA's Market Snapshot.
  • Pennsylvania + Wall
    Nov 06, 2026

    Getting the Foundation Right

    Key takeaways from SIFMA's 2026 Global Corporate Actions Forum on data standardization, AI, extended trading hours, tokenization and modernization.

Get the latest trends, stats, and research on financial markets and securities.